{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:55:20Z","timestamp":1787162120907,"version":"build-2736575974"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:00:00Z","timestamp":1623024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Genetic susceptibility to myasthenia gravis (MG) associates with specific HLA alleles and haplotypes at the class I and II regions in various populations. Previous studies have only examined alleles at a limited number of HLA loci that defined only broad serotypes or alleles defined at the protein sequence level. Consequently, genetic variants in noncoding and untranslated HLA gene segments have not been fully explored but could also be important determinants for MG. To gain further insight into the role of HLA in MG, we applied next-generation sequencing to analyze sequence variation at eleven HLA genes in early-onset (EO) and late-onset (LO) non-thymomatous MG patients positive for the acetylcholine receptor (AChR) antibodies and ethnically matched controls from Italy, Norway, and Sweden. For all three populations, alleles and haplotype blocks present on the ancestral haplotype AH8.1 were associated with risk in AChR-EOMG patients.\n                    <jats:italic>HLA-B*08:01:01:01<\/jats:italic>\n                    was the dominant risk allele in Italians (OR = 3.28,\n                    <jats:italic>P<\/jats:italic>\n                    = 1.83E\u221205), Norwegians (OR = 3.52,\n                    <jats:italic>P<\/jats:italic>\n                    = 4.41E\u221216), and in Swedes\n                    <jats:italic>HLA-B*08:01<\/jats:italic>\n                    was the primary risk allele (OR = 4.24, P &amp;lt;2.2E-16). Protective alleles and haplotype blocks were identified on the\n                    <jats:italic>HLA-DRB7<\/jats:italic>\n                    , and\n                    <jats:italic>HLA-DRB13.1<\/jats:italic>\n                    class II haplotypes in Italians and Norwegians, whereas in Swedes\n                    <jats:italic>HLA-DRB7<\/jats:italic>\n                    exhibited the main protective effect. For AChR-LOMG patients, the\n                    <jats:italic>HLA-DRB15.1<\/jats:italic>\n                    haplotype and associated alleles were significantly associated with susceptibility in all groups. The\n                    <jats:italic>HLA-DR13\u2013HLA-DR\u2013HLA-DQ<\/jats:italic>\n                    haplotype was associated with protection in all AChR-LOMG groups. This study has confirmed and extended previous findings that the immunogenetic predisposition profiles for EOMG and LOMG are distinct. In addition, the results are consistent with a role for non-coding HLA genetic variants in the pathogenesis of MG.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2021.667336","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:37:25Z","timestamp":1623026245000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Next-Generation Sequencing Identifies Extended HLA Class I and II Haplotypes Associated With Early-Onset and Late-Onset Myasthenia Gravis in Italian, Norwegian, and Swedish Populations"],"prefix":"10.3389","volume":"12","author":[{"given":"Lisa E.","family":"Creary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridevi","family":"Gangavarapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy J.","family":"Caillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cavalcante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Frangiamore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicte A.","family":"Lie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Bengtsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne Flinstad","family":"Harbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Brauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill A.","family":"Hollenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge R.","family":"Oksenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina Hatl\u00f8","family":"Maniaol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Hammarstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Mantegazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo A.","family":"Fern\u00e1ndez-Vi\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia Gravis","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat Rev Dis Prim"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia Gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia Gravis: Subgroup Classification and Therapeutic Strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A Systematic Review of Population Based Epidemiological Studies in Myasthenia Gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2016.44","article-title":"Myasthenia Gravis \u2014 Autoantibody Characteristics and Their Implications for Therapy","volume":"12","author":"Gilhus","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/J.COI.2017.07.006","article-title":"Pathophysiology and Immunological Profile of Myasthenia Gravis and Its Subgroups","volume":"49","author":"Romi","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"90\u2013100","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"Myasthenia Gravis: A Comprehensive Review of Immune Dysregulation and Etiological Mechanisms","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/J.AUTREV.2013.03.003","article-title":"Complement Associated Pathogenic Mechanisms in Myasthenia Gravis","volume":"12","author":"T\u00fcz\u00fcn","year":"2013","journal-title":"Autoimmun Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/J.JAUT.2013.12.004","article-title":"A Comprehensive Analysis of the Epidemiology and Clinical Characteristics of Anti-LRP4 in Myasthenia Gravis","volume":"52","author":"Zisimopoulou","year":"2014","journal-title":"J Autoimmun"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13300","article-title":"Multiple Antibody Detection in \u2018Seronegative\u2019 Myasthenia Gravis Patients","volume":"24","author":"Hong","year":"2017","journal-title":"Eur J Neurol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/ane.12233","article-title":"Myasthenia Gravis Epidemiology in a National Cohort; Combining Multiple Disease Registries","volume":"129","author":"Andersen","year":"2014","journal-title":"Acta Neurol Scand"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S146617","article-title":"Familial Aggregation of Myasthenia Gravis in Affected Families: A Population-Based Study","volume":"9","author":"Liu","year":"2017","journal-title":"Clin Epidemiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/J.JNS.2015.11.049","article-title":"Study of the Prevalence of Familial Autoimmune Myasthenia Gravis in a Spanish Cohort","volume":"360","author":"Salvado","year":"2016","journal-title":"J Neurol Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/cge.12118","article-title":"Exome Sequencing Detection of Two Untranslated","volume":"85","author":"Maselli","year":"2014","journal-title":"GFPT1 Mutations Family Limb-Girdle Myasthenia Clin Genet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/J.NMD.2011.10.004","article-title":"Three Cases of Myasthenia Gravis From One Family With Variations in Clinical Features and Serum Antibodies","volume":"22","author":"Chen","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-011-5964-6","article-title":"Familial Autoimmune MuSK Positive Myasthenia Gravis","volume":"258","author":"Corda","year":"2011","journal-title":"J Neurol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1375\/twin.14.2.129","article-title":"Utilizing Twins Concordance Rates to Infer the Predisposition to Myasthenia Gravis","volume":"14","author":"Ramanujam","year":"2011","journal-title":"Twin Res Hum Genet"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(74)92548-3","article-title":"Hl-a ANTIGENS in MYASTHENIA Gravis","volume":"303","author":"Fritze","year":"1974","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/tan.13305","article-title":"Autoimmune Diseases and 8.1 Ancestral Haplotype: An Update","volume":"92","author":"Gambino","year":"2018","journal-title":"HLA"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0406756101","article-title":"Pleiotropic Effects of the 8.1 HLA Haplotype in Patients With Autoimmune Myasthenia Gravis and Thymus Hyperplasia","volume":"101","author":"Vandiedonck","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/sj.gene.6364110","article-title":"Genetic Control of Autoantibody Expression in Autoimmune Myasthenia Gravis: Role of the Self-Antigen and of HLA-linked Loci","volume":"5","author":"Giraud","year":"2004","journal-title":"Genes Immun"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S0198-8859(99)00062-2","article-title":"A Susceptibility Region for Myasthenia Gravis Extending Into the HLA-Class I Sector Telomeric to HLA-C","volume":"60","author":"Janer","year":"1999","journal-title":"Hum Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/joim.12310","article-title":"The Autoimmune Spectrum of Myasthenia Gravis: A Swedish Population-Based Study","volume":"277","author":"Fang","year":"2015","journal-title":"J Intern Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/J.JAUT.2017.10.002","article-title":"Novel Genetic Loci Associated HLA-B*08:01 Positive Myasthenia Gravis","volume":"88","author":"Varade","year":"2018","journal-title":"J Autoimmun"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2015.00232","article-title":"Genome-Wide Association Study of Late-Onset Myasthenia Gravis: Confirmation of TNFRSF11A and Identification of ZBTB10 and Three Distinct HLA Associations","volume":"21","author":"Seldin","year":"2016","journal-title":"Mol Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036603","article-title":"Late Onset Myasthenia Gravis Is Associated With HLA DRB1*15:01 in the Norwegian Population","volume":"7","author":"Maniaol","year":"2012","journal-title":"PloS One"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09225-z","article-title":"Thymomatous Myasthenia Gravis: Novel Association With HLA DQB1*05:01 and Strengthened Evidence of High Clinical and Serological Severity","volume":"266","author":"Massa","year":"2019","journal-title":"J Neurol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/J.HUMIMM.2019.07.275","article-title":"Next-Generation Sequencing Reveals New Information About HLA Allele and Haplotype Diversity in a Large European American Population","volume":"80","author":"Creary","year":"2019","journal-title":"Hum Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/J.HUMIMM.2019.03.001","article-title":"Next-Generation HLA Typing of 382 International Histocompatibility Working Group Reference B-Lymphoblastoid Cell Lines: Report From the 17th International HLA and Immunogenetics Workshop","volume":"80","author":"Creary","year":"2019","journal-title":"Hum Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1177\/1352458518770019","article-title":"Deconstruction of HLA-DRB1*04:01:01 and HLA-DRB1*15:01:01 Class II Haplotypes Using Next-Generation Sequencing in European-Americans With Multiple Sclerosis","volume":"25","author":"Creary","year":"2018","journal-title":"Mult Scler J"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1821778116","article-title":"A Specific Amino Acid Motif of HLA-DRB1 Mediates Risk and Interacts With Smoking History in Parkinson\u2019s Disease","volume":"116","author":"Hollenbach","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2015.12.006","article-title":"Bridging ImmunoGenomic Data Analysis Workflow Gaps (Bigdawg): An Integrated Case-Control Analysis Pipeline","volume":"77","author":"Pappas","year":"2016","journal-title":"Hum Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/genetics\/117.2.331","article-title":"Gametic Disequilibrium Measures: Proceed With Caution","volume":"117","author":"Hedrick","year":"1987","journal-title":"Genetics"},{"key":"B34","volume-title":"Mathematical Methods of Statistics. I., Ed. H","author":"Cramer","year":"1946"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2006.00769.x","article-title":"PyPop Update\u2013a Software Pipeline for Large-Scale Multilocus Population Genomics","volume":"69","author":"Lancaster","year":"2007","journal-title":"Tissue Antigens"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.2307\/2532296","article-title":"Performing the Exact Test of Hardy-Weinberg Proportion for Multiple Alleles","volume":"48","author":"Guo","year":"1992","journal-title":"Biometrics"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/948723","article-title":"The Protective Role of HLA-DRB1(\u2217)13 in Autoimmune Diseases","volume":"2015","author":"Bettencourt","year":"2015","journal-title":"J Immunol Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"81\u20138","DOI":"10.1016\/j.clim.2016.05.003","article-title":"Genetic Heterogeneity Within the HLA Region in Three Distinct Clinical Subgroups of Myasthenia Gravis","author":"Saruhan-Direskeneli","year":"2016","journal-title":"Clin Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-011-0223-x","article-title":"Genetics of the HLA Region in the Prediction of Type 1 Diabetes","volume":"11","author":"Noble","year":"2011","journal-title":"Curr Diabetes Rep"},{"key":"B40","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00281-006-0031-6","article-title":"Current Topics in Human SLE Genetics","volume":"28","author":"Wong","year":"2006","journal-title":"Springer Semin Immunopathol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00321","article-title":"Mhc Class Ii Polymorphisms, Autoreactive\u2009T-Cells, and Autoimmunity","volume":"4","author":"Tsai","year":"2013","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/J.NMD.2017.04.002","article-title":"HLA and Age of Onset in Myasthenia Gravis","volume":"27","author":"Santos","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/J.JOCN.2011.05.002","article-title":"Association Between HLA-DRB1 and Myasthenia Gravis in a Northern Han Chinese Population","volume":"18","author":"Xie","year":"2011","journal-title":"J Clin Neurosci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-015-2235-9","article-title":"The HLA-B*4601-DRB1*0901 Haplotype Is Positively Correlated With Juvenile Ocular Myasthenia Gravis in a Southern Chinese Han Population","volume":"36","author":"Feng","year":"2015","journal-title":"Neurol Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/gene.2016.40","article-title":"The Role of Common Protective Alleles HLA-DRB1*13 Among Systemic Autoimmune Diseases","volume":"18","author":"Furukawa","year":"2017","journal-title":"Genes Immun"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.111906","article-title":"Major Histocompatibility Complex (MHC) Class II Alleles, Haplotypes and Epitopes Which Confer Susceptibility or Protection in Systemic Sclerosis: Analyses in 1300 Caucasian, African-American and Hispanic Cases and 1000 Controls","volume":"69","author":"Arnett","year":"2010","journal-title":"Ann Rheum Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.667336\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:37:28Z","timestamp":1623026248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.667336\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,7]]},"references-count":46,"alternative-id":["10.3389\/fimmu.2021.667336"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.667336","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,7]]},"article-number":"667336"}}